AC Immune SA (ACIU)

AC Immune SA (ACIU) Financial Statements


AC Immune SA Financial Overview

AC Immune SA's market cap is currently ―. The company's EPS TTM is $-0.885; its P/E ratio is -2.42; AC Immune SA is scheduled to report earnings on April 27, 2023, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total RevenueSFr. 3.93MSFr. 0.00SFr. 0.00SFr. 0.00SFr. 0.00
Gross Profit-----
EBITSFr. -13.44MSFr. -19.51MSFr. -18.69MSFr. -21.10MSFr. -15.74M
EBITDASFr. -12.86MSFr. -18.94MSFr. -18.09MSFr. -20.47MSFr. -15.10M
Net Income Common StockholdersSFr. -13.52MSFr. -19.64MSFr. -18.85MSFr. -21.28MSFr. -15.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsSFr. 140.50MSFr. 154.15MSFr. 173.84MSFr. 198.22MSFr. 188.58M
Total AssetsSFr. 205.56MSFr. 216.79MSFr. 235.52MSFr. 261.44MSFr. 203.40M
Total DebtSFr. 2.48MSFr. 2.63MSFr. 2.77MSFr. 2.91MSFr. 2.57M
Net DebtSFr. -138.02MSFr. -151.52MSFr. -171.07MSFr. -195.31MSFr. -186.01M
Total LiabilitiesSFr. 15.50MSFr. 13.97MSFr. 21.39MSFr. 29.46MSFr. 24.18M
Stockholders EquitySFr. 190.05MSFr. 202.81MSFr. 214.13MSFr. 231.98MSFr. 179.22M
Cash Flow-
Free Cash FlowSFr. -13.66MSFr. -20.02MSFr. -23.68MSFr. -18.55MSFr. -14.99M
Operating Cash FlowSFr. -13.54MSFr. -19.48MSFr. -23.14MSFr. -17.83MSFr. -14.50M
Investing Cash FlowSFr. -5.12MSFr. 24.46MSFr. -540.00KSFr. -21.72MSFr. -495.00K
Financing Cash FlowSFr. -142.00KSFr. -137.00KSFr. -916.00KSFr. 28.73MSFr. 4.33M
Currency in CHF

AC Immune SA Earnings and Revenue History

AC Immune SA Debt to Assets

AC Immune SA Cash Flow

AC Immune SA Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis